Temozolomide (TMZ) plus thalidomide (THAL) as adjuvant therapy in patients with stage III and stage IV malignant melanoma Meeting Abstract
| Authors: | Hwu, W. J.; Coit, D.; Jaques, D.; Panageas, K. S.; Lamb, L. A.; Quinn, C. J. |
| Abstract Title: | Temozolomide (TMZ) plus thalidomide (THAL) as adjuvant therapy in patients with stage III and stage IV malignant melanoma |
| Meeting Title: | 40th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 22 |
| Issue: | 14 Suppl. |
| Meeting Dates: | 2004 Jun 5-8 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2004-07-15 |
| Start Page: | 728S |
| Language: | English |
| ACCESSION: | WOS:000223512402888 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2004.22.90140.7574 |
| Notes: | Meeting Abstract: 7574 -- 40th Annual Meeting of the American-Society-of-Clinical-Oncology -- JUN 05-08, 2004 -- New Orleans, LA -- S -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work